A Randomized Phase II Study Evaluating Pembrolizumab vs Topotecan in the Second-line Treatment of Patients with Small Cell Lung Cancer
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
TESARO
Start Date
January 4, 2018
End Date
September 21, 2020
Administered By
Duke Cancer Institute
Awarded By
TESARO
Start Date
January 4, 2018
End Date
September 21, 2020